Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes
Not Applicable
- Conditions
- DiabetesDiabetes Type 2Pre-diabetes
- Registration Number
- NCT04905485
- Lead Sponsor
- Viome
- Brief Summary
Participants who were previously Viome costumers who signed informed consent to participate and self reported type 2 diabetes or pre-diabetes were enrolled. They provided stool samples to VIOME and were provided with precision diet and supplement recommendations. The information obtained from this study is used to train a model to predict diabetes and/or risks of developing diabetes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2912
Inclusion Criteria
- Viome customer
- GI test collected at home using Viome test kit
- US citizen
- 18+ years old
- Is not participating in any other Viome study
- Must have answered the following on-boarding question with the indicated answer:
"Do you or did you ever have diabetes or prediabetes?"
- Signed and dated informed consent prior to any trial-specific procedures are performed
- Able to speak and read English
- Willing and able to follow the trial instructions
Exclusion Criteria
- Unable/unwilling to complete the informed consent form and the questionnaires
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Difference in VIOME's Type 2 diabetes risk score ~3 months "Type 2 diabetes risk score" is computed using Viome's molecular data from stool and HBA1C level self reported. The risk score is 1-100. 1 Indicates a low chance of developing T2D and 100 indicates a high chance of developing T2D.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Viome Research Institute
🇺🇸Bothell, Washington, United States
Viome Research Institute🇺🇸Bothell, Washington, United States